1. Home
  2. AMLX
  3. AMLX News

Latest Amylyx Pharmaceuticals Inc. (AMLX) News on October 25, 2025

Why Shares in Amylyx Pharmaceuticals Soared This Week
AMLX

Motley Fool

4 months ago

Why Shares in Amylyx Pharmaceuticals Soared This Week

Amylyx Pharmaceuticals Gains FDA Fast Track for ALS Drug AMX0114
AMLX

Insider Monkey

4 months ago

Amylyx Pharmaceuticals Gains FDA Fast Track for ALS Drug AMX0114

AMLX

MT Newswires

4 months ago

Guggenheim Initiates Amylyx Pharmaceuticals at Buy With $17 Price Target

AMLX

MT Newswires

5 months ago

Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday

AMLX

MT Newswires

5 months ago

Amylyx Pharmaceuticals' Potential ALS Treatment Gets FDA Fast Track Designation

Amylyx Pharmaceuticals Receives U.S. FDA Fast Track Designation for AMX0114 for the Treatment of Amyotrophic Lateral Sclerosis
AMLX

Business Wire

5 months ago

Amylyx Pharmaceuticals Receives U.S. FDA Fast Track Designation for AMX0114 for the Treatment of Amyotrophic Lateral Sclerosis

AMLX

MT Newswires

5 months ago

TD Cowen Initiates Coverage on Amylyx Pharmaceuticals With Buy Rating

Amylyx Pharmaceuticals to Participate in Upcoming June Investor Conferences
AMLX

Business Wire

5 months ago

Amylyx Pharmaceuticals to Participate in Upcoming June Investor Conferences

Wall Street Analysts See a 105.22% Upside in Amylyx Pharmaceuticals (AMLX): Can the Stock Really Move This High?
AMLX

Zacks

5 months ago

Wall Street Analysts See a 105.22% Upside in Amylyx Pharmaceuticals (AMLX): Can the Stock Really Move This High?

AMLX

MT Newswires

5 months ago

Mizuho Adjusts Price Target on Amylyx Pharmaceuticals to $8 From $7, Maintains Outperform Rating

Amylyx Pharmaceuticals Announces Positive Long-Term Results from Phase 2 HELIOS Clinical Trial of AMX0035 in People with Wolfram Syndrome
AMLX

Business Wire

5 months ago

Amylyx Pharmaceuticals Announces Positive Long-Term Results from Phase 2 HELIOS Clinical Trial of AMX0035 in People with Wolfram Syndrome

Here's Why We're A Bit Worried About Amylyx Pharmaceuticals' (NASDAQ:AMLX) Cash Burn Situation
AMLX

Simply Wall St.

6 months ago

Here's Why We're A Bit Worried About Amylyx Pharmaceuticals' (NASDAQ:AMLX) Cash Burn Situation

AMLX

GuruFocus.com

6 months ago

Amylyx Pharmaceuticals Inc (AMLX) Q1 2025 Earnings Call Highlights: Strategic Advances and ...

Amylyx Pharmaceuticals Reports First Quarter 2025 Financial Results
AMLX

Business Wire

6 months ago

Amylyx Pharmaceuticals Reports First Quarter 2025 Financial Results

AMLX

MT Newswires

6 months ago

Amylyx Pharmaceuticals Shares Rise After Upgrade From Leerink

Amylyx Pharmaceuticals to Participate in Upcoming May Investor Conferences
AMLX

Business Wire

6 months ago

Amylyx Pharmaceuticals to Participate in Upcoming May Investor Conferences

AMLX

MT Newswires

6 months ago

Leerink Upgrades Amylyx Pharmaceuticals to Outperform From Market Perform, Adjusts Price Target to $10 From $4

Amylyx Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025
AMLX

Business Wire

6 months ago

Amylyx Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025

Amylyx doses first subject in trial of post-bariatric hypoglycaemia treatment
AMLX

Clinical Trials Arena

6 months ago

Amylyx doses first subject in trial of post-bariatric hypoglycaemia treatment

AMLX

MT Newswires

6 months ago

Sector Update: Health Care Stocks Rise Wednesday Afternoon

AMLX

MT Newswires

6 months ago

Amylyx Pharmaceuticals Starts Dosing in Phase 3 Trial for Post-Bariatric Hypoglycemia Treatment

Amylyx Pharmaceuticals Announces First Participant Dosed in Pivotal Phase 3 LUCIDITY Trial of Avexitide in Post-Bariatric Hypoglycemia
AMLX

Business Wire

6 months ago

Amylyx Pharmaceuticals Announces First Participant Dosed in Pivotal Phase 3 LUCIDITY Trial of Avexitide in Post-Bariatric Hypoglycemia

Is Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) the Best Biotech Penny Stock to Buy According to Hedge Funds?
AMLX

Insider Monkey

6 months ago

Is Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) the Best Biotech Penny Stock to Buy According to Hedge Funds?

Amgen says Imdelltra extended survival; Parker Institute adds new leaders
AMLX

BioPharma Dive

6 months ago

Amgen says Imdelltra extended survival; Parker Institute adds new leaders

First subject dosed in Amylyx’s Phase I trial of ALS therapy
AMLX

Clinical Trials Arena

7 months ago

First subject dosed in Amylyx’s Phase I trial of ALS therapy

Amylyx Pharmaceuticals Announces First Participant Dosed in Phase 1, Multiple Ascending Dose LUMINA Trial of AMX0114 in People Living with Amyotrophic Lateral Sclerosis
AMLX

Business Wire

7 months ago

Amylyx Pharmaceuticals Announces First Participant Dosed in Phase 1, Multiple Ascending Dose LUMINA Trial of AMX0114 in People Living with Amyotrophic Lateral Sclerosis

AMLX

MT Newswires

7 months ago

Mizuho Upgrades Amylyx Pharmaceuticals to Outperform From Neutral, Raises Price Target to $7 From $3

Amylyx Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
AMLX

Business Wire

7 months ago

Amylyx Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference

Is Amylyx Pharmaceuticals (AMLX) The Hot Biotech Stock Under $5?
AMLX

Insider Monkey

7 months ago

Is Amylyx Pharmaceuticals (AMLX) The Hot Biotech Stock Under $5?

March 2025's Top Penny Stocks To Watch
AMLX

Simply Wall St.

8 months ago

March 2025's Top Penny Stocks To Watch

AMLX

GuruFocus.com

8 months ago

Amylyx Pharmaceuticals Inc (AMLX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...

Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results
AMLX

Business Wire

8 months ago

Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results

AMLX

GuruFocus.com

8 months ago

Amylyx Pharmaceuticals Inc (AMLX) Q4 2024: Everything You Need To Know Ahead Of Earnings

Amylyx Pharmaceuticals to Participate in Upcoming March Investor Conferences
AMLX

Business Wire

8 months ago

Amylyx Pharmaceuticals to Participate in Upcoming March Investor Conferences

Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
AMLX

Business Wire

8 months ago

Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

Amylyx Pharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
AMLX

Business Wire

8 months ago

Amylyx Pharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

February 2025's Promising Penny Stocks On US Exchanges
AMLX

Simply Wall St.

9 months ago

February 2025's Promising Penny Stocks On US Exchanges

Amylyx Pharmaceuticals (AMLX) Upgraded to Buy: What Does It Mean for the Stock?
AMLX

Zacks

9 months ago

Amylyx Pharmaceuticals (AMLX) Upgraded to Buy: What Does It Mean for the Stock?

Intellia makes progress on HAE study; 2 more China drug deals
AMLX

BioPharma Dive

9 months ago

Intellia makes progress on HAE study; 2 more China drug deals

AMLX

MT Newswires

9 months ago

Amylyx Pharmaceuticals Says FDA Lifts Clinical Hold on Phase 1 ALS Study

Amylyx Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on AMX0114 Phase 1 Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis
AMLX

Business Wire

9 months ago

Amylyx Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on AMX0114 Phase 1 Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis

AMLX

MT Newswires

9 months ago

Amylyx Pharmaceuticals Prices $60 Million Common Stock Offering

Amylyx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
AMLX

Business Wire

9 months ago

Amylyx Pharmaceuticals Announces Pricing of Public Offering of Common Stock

AMLX

MT Newswires

10 months ago

Amylyx Pharmaceuticals Launches Stock Offering

Amylyx Pharmaceuticals Announces Proposed Public Offering of Common Stock
AMLX

Business Wire

10 months ago

Amylyx Pharmaceuticals Announces Proposed Public Offering of Common Stock

Cerus And 2 Other US Penny Stocks With Promising Potential
AMLX

Simply Wall St.

10 months ago

Cerus And 2 Other US Penny Stocks With Promising Potential

Amylyx Pharmaceuticals Appoints Dan Monahan as Chief Commercial Officer
AMLX

Business Wire

10 months ago

Amylyx Pharmaceuticals Appoints Dan Monahan as Chief Commercial Officer

AMLX

MT Newswires

10 months ago

Amylyx Pharmaceuticals, Gubra Collaborate on GLP-1 Therapy Development

Why Is Amylyx Pharmaceuticals (AMLX) Among the Best Biotech Penny Stocks to Invest in Now?
AMLX

Insider Monkey

10 months ago

Why Is Amylyx Pharmaceuticals (AMLX) Among the Best Biotech Penny Stocks to Invest in Now?

Amylyx announces design of LUCIDITY clinical trial
AMLX

TipRanks

a year ago

Amylyx announces design of LUCIDITY clinical trial

Amylyx Pharmaceuticals Announces Pivotal Phase 3 LUCIDITY Trial Design for GLP-1 Receptor Antagonist (Avexitide) in Post-Bariatric Hypoglycemia
AMLX

Business Wire

a year ago

Amylyx Pharmaceuticals Announces Pivotal Phase 3 LUCIDITY Trial Design for GLP-1 Receptor Antagonist (Avexitide) in Post-Bariatric Hypoglycemia

Amylyx Pharmaceuticals to Present at the 7th Annual Evercore ISI HealthCONx Conference
AMLX

Business Wire

a year ago

Amylyx Pharmaceuticals to Present at the 7th Annual Evercore ISI HealthCONx Conference

AMLX

MT Newswires

a year ago

Baird Upgrades Amylyx Pharmaceuticals to Outperform From Neutral, Adjusts Price Target to $11 From $3

Amylyx Pharmaceuticals Third Quarter 2024 Earnings: US$1.07 loss per share (vs US$0.31 profit in 3Q 2023)
AMLX

Simply Wall St.

a year ago

Amylyx Pharmaceuticals Third Quarter 2024 Earnings: US$1.07 loss per share (vs US$0.31 profit in 3Q 2023)

AMLX

GuruFocus.com

a year ago

Amylyx Pharmaceuticals Inc (AMLX) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...

AMLX

Thomson Reuters StreetEvents

a year ago

Q3 2024 Amylyx Pharmaceuticals Inc Earnings Call

Amylyx Pharmaceuticals Reports Third Quarter 2024 Financial Results
AMLX

Business Wire

a year ago

Amylyx Pharmaceuticals Reports Third Quarter 2024 Financial Results

Amylyx Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024
AMLX

Business Wire

a year ago

Amylyx Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024

Perceptive Advisors LLC's Strategic Acquisition in Amylyx Pharmaceuticals Inc
AMLX

GuruFocus.com

a year ago

Perceptive Advisors LLC's Strategic Acquisition in Amylyx Pharmaceuticals Inc

AMLX

MT Newswires

a year ago

Amylyx Pharmaceuticals Shares Rise After BofA Upgrade

AMLX

MT Newswires

a year ago

BofA Securities Upgrades Amylyx Pharmaceuticals to Buy From Neutral, Price Target is $10

October 2024's US Penny Stocks Poised For Growth
AMLX

Simply Wall St.

a year ago

October 2024's US Penny Stocks Poised For Growth

Amylyx Pharmaceuticals (AMLX): Leading Nano Cap in Neurodegenerative Disease Treatments
AMLX

Insider Monkey

a year ago

Amylyx Pharmaceuticals (AMLX): Leading Nano Cap in Neurodegenerative Disease Treatments

Amylyx’s AMX0035 shows promise in Phase II Wolfram syndrome trial
AMLX

Clinical Trials Arena

a year ago

Amylyx’s AMX0035 shows promise in Phase II Wolfram syndrome trial

Why Amylyx Pharmaceuticals Stock Was So Healthy This Week
AMLX

Motley Fool

a year ago

Why Amylyx Pharmaceuticals Stock Was So Healthy This Week

PTC rebuffed again by EMA; Novartis licenses China-based biotech’s cancer drug
AMLX

BioPharma Dive

a year ago

PTC rebuffed again by EMA; Novartis licenses China-based biotech’s cancer drug

AMLX

MT Newswires

a year ago

Amylyx Pharmaceuticals Shares Jump After Wolfram Syndrome Treatment Study Shows Improvement

Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 2 HELIOS Clinical Trial Demonstrating Sustained Improvements with AMX0035 in People Living with Wolfram Syndrome
AMLX

Business Wire

a year ago

Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 2 HELIOS Clinical Trial Demonstrating Sustained Improvements with AMX0035 in People Living with Wolfram Syndrome

Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Topline Results from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on October 17, 2024
AMLX

Business Wire

a year ago

Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Topline Results from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on October 17, 2024

AMLX

GuruFocus.com

a year ago

Amylyx Pharmaceuticals Inc (AMLX) Q2 2024 Earnings Call Highlights: Strategic Pipeline ...

Director Karen Firestone Acquires 50,000 Shares of Amylyx Pharmaceuticals Inc (AMLX)
AMLX

GuruFocus.com

a year ago

Director Karen Firestone Acquires 50,000 Shares of Amylyx Pharmaceuticals Inc (AMLX)

AMLX

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 09/06/2024

Director MILNE GEORGE M JR Acquires 100,000 Shares of Amylyx Pharmaceuticals Inc (AMLX)
AMLX

GuruFocus.com

a year ago

Director MILNE GEORGE M JR Acquires 100,000 Shares of Amylyx Pharmaceuticals Inc (AMLX)

Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences
AMLX

Business Wire

a year ago

Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences

Amylyx Pharmaceuticals Announces Publication of Data Showing the Encouraging Effects of AMX0035 on Cerebrospinal Fluid Biomarkers of Core Alzheimer’s Disease Pathology and Neurodegeneration
AMLX

Business Wire

a year ago

Amylyx Pharmaceuticals Announces Publication of Data Showing the Encouraging Effects of AMX0035 on Cerebrospinal Fluid Biomarkers of Core Alzheimer’s Disease Pathology and Neurodegeneration

We Think Amylyx Pharmaceuticals (NASDAQ:AMLX) Can Easily Afford To Drive Business Growth
AMLX

Simply Wall St.

a year ago

We Think Amylyx Pharmaceuticals (NASDAQ:AMLX) Can Easily Afford To Drive Business Growth

Amylyx Pharmaceuticals Reports Second Quarter 2024 Financial Results
AMLX

Business Wire

a year ago

Amylyx Pharmaceuticals Reports Second Quarter 2024 Financial Results

Madrigal (MDGL) Reports Q2 Loss, Tops Revenue Estimates
AMLX

Zacks

a year ago

Madrigal (MDGL) Reports Q2 Loss, Tops Revenue Estimates

Amylyx Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024
AMLX

Business Wire

a year ago

Amylyx Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024

EC grants orphan drug status for Amylyx’s Wolfram treatment
AMLX

Pharmaceutical Technology

a year ago

EC grants orphan drug status for Amylyx’s Wolfram treatment

AMLX

MT Newswires

a year ago

Amylyx Pharmaceuticals' Receives EU Orphan Designation for Potential Wolfram Syndrome Drug

Amylyx Pharmaceuticals Receives Orphan Drug Designation From the European Commission for AMX0035 for the Treatment of Wolfram Syndrome
AMLX

Business Wire

a year ago

Amylyx Pharmaceuticals Receives Orphan Drug Designation From the European Commission for AMX0035 for the Treatment of Wolfram Syndrome

AMLX

MT Newswires

a year ago

Goldman Sachs Adjusts Price Target on Amylyx Pharmaceuticals to $4 From $3, Maintains Neutral Rating

Amylyx to rebuild pipeline with $35m Phase III ready GLP-1RA acquisition
AMLX

Clinical Trials Arena

a year ago

Amylyx to rebuild pipeline with $35m Phase III ready GLP-1RA acquisition

AMLX

MT Newswires

a year ago

Amylyx Pharmaceuticals Acquires Avexitide From Eiger BioPharmaceuticals for $35 Million

Amylyx Pharmaceuticals Announces Acquisition of Phase 3-ready GLP-1 Receptor Antagonist (Avexitide) with FDA Breakthrough Therapy Designation
AMLX

Business Wire

a year ago

Amylyx Pharmaceuticals Announces Acquisition of Phase 3-ready GLP-1 Receptor Antagonist (Avexitide) with FDA Breakthrough Therapy Designation

Amylyx, with GLP-1 buy, doubles down on blood sugar drugs
AMLX

BioPharma Dive

a year ago

Amylyx, with GLP-1 buy, doubles down on blood sugar drugs

Amylyx Pharmaceuticals to Host Conference Call to Discuss the Acquisition of Avexitide
AMLX

Business Wire

a year ago

Amylyx Pharmaceuticals to Host Conference Call to Discuss the Acquisition of Avexitide

Amylyx ventures into metabolic diseases market with $35.1m deal
AMLX

Pharmaceutical Technology

a year ago

Amylyx ventures into metabolic diseases market with $35.1m deal

Amylyx Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
AMLX

Business Wire

a year ago

Amylyx Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

AMLX

MT Newswires

a year ago

Mizuho Cuts Price Target on Amylyx Pharmaceuticals to $3 From $4, Keeps Neutral Rating

Amylyx Pharmaceuticals Reports Q1 2024 Financial Results
AMLX

GuruFocus.com

a year ago

Amylyx Pharmaceuticals Reports Q1 2024 Financial Results

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q1 2024 Earnings Call Transcript
AMLX

Insider Monkey

a year ago

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q1 2024 Earnings Call Transcript

Amylyx Pharmaceuticals, Inc. (AMLX) Reports Q1 Loss, Lags Revenue Estimates
AMLX

Zacks

a year ago

Amylyx Pharmaceuticals, Inc. (AMLX) Reports Q1 Loss, Lags Revenue Estimates

Amylyx Pharmaceuticals Reports First Quarter 2024 Financial Results
AMLX

Business Wire

a year ago

Amylyx Pharmaceuticals Reports First Quarter 2024 Financial Results

Amylyx Pharmaceuticals to Present at the 2024 Bank of America Health Care Conference
AMLX

Business Wire

a year ago

Amylyx Pharmaceuticals to Present at the 2024 Bank of America Health Care Conference

Amylyx Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024
AMLX

Business Wire

a year ago

Amylyx Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024

Trials to watch: Four ALS drugs to keep an eye on
AMLX

Clinical Trials Arena

a year ago

Trials to watch: Four ALS drugs to keep an eye on

The Zacks Analyst Blog Highlights Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and Syros Pharmaceuticals
AMLX

Zacks

2 years ago

The Zacks Analyst Blog Highlights Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and Syros Pharmaceuticals

Amylyx Pharmaceuticals' Investigational Drug Shows Improved Pancreatic Function In Patients With Inherited Disorder
AMLX

Benzinga

2 years ago

Amylyx Pharmaceuticals' Investigational Drug Shows Improved Pancreatic Function In Patients With Inherited Disorder

Share on Social Networks: